Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


20.03.2017

17 AIDS
5 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
1 BMC Pediatr
2 BMJ
1 Br J Haematol
4 HIV Med
9 J Acquir Immune Defic Syndr
1 J Virol
3 JAMA
1 Lancet
1 Lancet Public Health
3 Nature
2 Neurology
2 Pediatrics
11 PLoS One
2 Science
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MAHIANE SG, Marsh K, Grantham K, Crichlow S, et al
    Improvements in Spectrum's fit to program data tool.
    AIDS. 2017;31 Suppl 1:S23-S30.
    PubMed     Text format     Abstract available

  2. CASE KK, Gregson S, Mahy M, Ghys PD, et al
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS. 2017;31 Suppl 1:S1-S4.
    PubMed     Text format    

  3. STOVER J, Brown T, Puckett R, Peerapatanapokin W, et al
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS. 2017;31 Suppl 1:S5-S11.
    PubMed     Text format     Abstract available

  4. ANDEREGG N, Johnson LF, Zaniewski E, Althoff KN, et al
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS. 2017;31 Suppl 1:S31-S40.
    PubMed     Text format     Abstract available

  5. SILHOL R, Gregson S, Nyamukapa C, Mhangara M, et al
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS. 2017;31 Suppl 1:S41-S50.
    PubMed     Text format     Abstract available

  6. NIU X, Zhang A, Brown T, Puckett R, et al
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS. 2017;31 Suppl 1:S51-S59.
    PubMed     Text format     Abstract available

  7. EATON JW, Bao L
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS. 2017;31 Suppl 1:S61-S68.
    PubMed     Text format     Abstract available

  8. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS. 2017;31 Suppl 1:S69-S76.
    PubMed     Text format     Abstract available

  9. MASQUELIER B, Eaton JW, Gerland P, Pelletier F, et al
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS. 2017;31 Suppl 1:S77-S85.
    PubMed     Text format     Abstract available

  10. SHENG B, Marsh K, Slavkovic AB, Gregson S, et al
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS. 2017;31 Suppl 1:S87-S94.
    PubMed     Text format     Abstract available

  11. WILSON KC, Mhangara M, Dzangare J, Eaton JW, et al
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS. 2017;31 Suppl 1:S95-S102.
    PubMed     Text format     Abstract available

  12. MCALLISTER J, Towns JM, Mcnulty A, Pierce AB, et al
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447.
    PubMed     Text format     Abstract available

  13. MANGAL TD
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437.
    PubMed     Text format     Abstract available

  14. MOTA TM, Rasmussen TA, Rhodes A, Tennakoon S, et al
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001442.
    PubMed     Text format     Abstract available

  15. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    PubMed     Text format     Abstract available

  16. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    PubMed     Text format     Abstract available

  17. MAHY M, Penazzato M, Ciaranello A, Mofenson L, et al
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS. 2017;31 Suppl 1:S13-S22.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  18. WANG Y, Kong D, Xu W, Li F, et al
    Identification of a Novel HIV Type 1 CRF01_AE/B'/C Recombinant Isolate in Sichuan, China.
    AIDS Res Hum Retroviruses. 2017 Mar 13. doi: 10.1089/aid.2017.0002.
    PubMed     Text format     Abstract available

  19. LI F, Li Y, Feng Y, Hu J, et al
    Four close related HIV-1 CRF01_AE/CRF07_BC Recombinant Forms identified in east China.
    AIDS Res Hum Retroviruses. 2017 Mar 16. doi: 10.1089/AID.2017.0049.
    PubMed     Text format     Abstract available

  20. NEGI BS, Kotaki T, Joshi SK, Bastola A, et al
    Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral drug-treated individuals residing in earthquake-affected areas in Nepal.
    AIDS Res Hum Retroviruses. 2017 Mar 16. doi: 10.1089/AID.2017.0047.
    PubMed     Text format     Abstract available

  21. CHRISTENSEN B, Qin Z, Byrd DA, Yu F, et al
    Measures of Physical and Mental Independence among HIV-positive Individuals: Impact of Substance Use Disorder.
    AIDS Res Hum Retroviruses. 2017 Mar 13. doi: 10.1089/AID.2016.0269.
    PubMed     Text format     Abstract available

  22. HEY-NGUYEN WJ, Xu Y, Pearson CF, Bailey M, et al
    Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2017 Mar 13. doi: 10.1089/aid.2016.0171.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  23. MOYA B, Barcelo IM, Bhagwat S, Patel M, et al
    WCK 5107 (Zidebactam) & WCK 5153: Novel inhibitors of PBP2 showing potent "beta-lactam enhancer" activity against Pseudomonas aeruginosa, including multidrug-resistant metallo-beta-lactamase-producing high-risk clones.
    Antimicrob Agents Chemother. 2017 Mar 13. pii: AAC.02529.
    PubMed     Text format     Abstract available


    Antivir Ther

  24. PETOUMENOS K, Choi JY, Hoy J, Kiertiburanakul S, et al
    CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy.
    Antivir Ther. 2017 Mar 14. doi: 10.3851/IMP3155.
    PubMed     Text format     Abstract available


    BMC Pediatr

  25. ROSALA-HALLAS A, Bartlett JW, Filteau S
    Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.
    BMC Pediatr. 2017;17:80.
    PubMed     Text format     Abstract available


    BMJ

  26. KHAN M, Rao PK, Rao RC
    A brushfire in the eye.
    BMJ. 2016;353:i3075.
    PubMed     Text format    

  27. VAN DE PERRE P, Kankasa C, Nagot N, Meda N, et al
    Pre-exposure prophylaxis for infants exposed to HIV through breast feeding.
    BMJ. 2017;356:j1053.
    PubMed     Text format    


    Br J Haematol

  28. OLAYEMI E, Asare EV, Benneh-Akwasi Kuma AA
    Guidelines in lower-middle income countries.
    Br J Haematol. 2017 Mar 14. doi: 10.1111/bjh.14583.
    PubMed     Text format     Abstract available


    HIV Med

  29. SOCIAS ME, Ti L, Dong H, Shoveller J, et al
    High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12501.
    PubMed     Text format     Abstract available

  30. MONROE AK, Zhang L, Jacobson LP, Plankey MW, et al
    The association between physical activity and cognition in men with and without HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12490.
    PubMed     Text format     Abstract available

  31. BROWN J, McGowan JA, Chouial H, Capocci S, et al
    Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12497.
    PubMed     Text format     Abstract available

  32. ERB S, Letang E, Glass TR, Natamatungiro A, et al
    Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12499.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  33. ARRIBAS JR, Thompson M, Sax PE, Haas B, et al
    A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.
    J Acquir Immune Defic Syndr. 2017 Mar 9. doi: 10.1097/QAI.0000000000001350.
    PubMed     Text format     Abstract available

  34. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001354.
    PubMed     Text format     Abstract available

  35. KAHN J, Xu J, Kapogiannis BG, Sleasman JW, et al
    Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001355.
    PubMed     Text format     Abstract available

  36. THOMSON KA, Haberer JE, Marzinke M, Mujugira A, et al
    Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001356.
    PubMed     Text format     Abstract available

  37. COELHO LE, Ribeiro SR, Japiassu AM, Moreira RI, et al
    30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001352.
    PubMed     Text format     Abstract available

  38. NACHEGA JB, Uthman OA, Mofenson LM, Anderson JR, et al
    Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001359.
    PubMed     Text format     Abstract available

  39. LUI G, Ma RC, Chook P, Wong CK, et al
    Progression of Atherosclerosis in HIV-infected Individuals - Prospective Data from an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001358.
    PubMed     Text format     Abstract available

  40. TOMITA A, Vandormael AM, Barnighausen T, de Oliveira T, et al
    Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001349.
    PubMed     Text format     Abstract available

  41. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001351.
    PubMed     Text format     Abstract available


    J Virol

  42. BAIG TT, Feng Y, Chelico L
    Correction for Baig et al., Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif.
    J Virol. 2017;91.
    PubMed     Text format    


    JAMA


  43. Blacks Still Trail in HIV Care.
    JAMA. 2017;317:1010.
    PubMed     Text format    

  44. CAREY AL, Khan MU, Engleberg NC
    A 24-Year-Old Man With a Left Frontal Brain Mass.
    JAMA. 2017;317:527-528.
    PubMed     Text format    


  45. Black Women Make Progress in Reducing HIV Disparity.
    JAMA. 2017;317:1010.
    PubMed     Text format    


    Lancet

  46. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    PubMed     Text format     Abstract available


    Lancet Public Health

  47. BURCH LS, Smith CJ, Anderson J, Sherr L, et al
    Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.
    Lancet Public Health. 2016;1:e26-e36.
    PubMed     Text format     Abstract available


    Nature

  48. NISHIMURA Y, Gautam R, Chun TW, Sadjadpour R, et al
    Early antibody therapy can induce long-lasting immunity to SHIV.
    Nature. 2017 Mar 13. doi: 10.1038/nature21435.
    PubMed     Text format     Abstract available

  49. DESCOURS B, Petitjean G, Lopez-Zaragoza JL, Bruel T, et al
    CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Nature. 2017 Mar 15. doi: 10.1038/nature21710.
    PubMed     Text format     Abstract available

  50. RICHMAN DD
    HIV: Finding latent needles in a haystack.
    Nature. 2017 Mar 15. doi: 10.1038/nature21899.
    PubMed     Text format    


    Neurology

  51. LLOYD TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, et al
    Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003821.
    PubMed     Text format     Abstract available

  52. ABSINTA M, Cortese IC, Vuolo L, Nair G, et al
    Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003820.
    PubMed     Text format     Abstract available


    Pediatrics

  53. CLAYTON HB, Lowry R, Ashley C, Wolkin A, et al
    Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.
    Pediatrics. 2017 Mar 13. pii: e20162675. doi: 10.1542/peds.2016-2675.
    PubMed     Text format     Abstract available

  54. NAYAKWADI SINGER M, Heath C, Muinde J, Gildengorin V, et al
    Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood.
    Pediatrics. 2017 Mar 16. pii: e20162781. doi: 10.1542/peds.2016-2781.
    PubMed     Text format     Abstract available


    PLoS One

  55. DE BREE GJ, Wheatley AK, Lynch RM, Prabhakaran M, et al
    Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection.
    PLoS One. 2017;12:e0173577.
    PubMed     Text format     Abstract available

  56. COURTNEY CR, Mayr L, Nanfack AJ, Banin AN, et al
    Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.
    PLoS One. 2017;12:e0173705.
    PubMed     Text format     Abstract available

  57. TADESSE SE, Seid O, G/Mariam Y, Fekadu A, et al
    Determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia, unmatched case -control study.
    PLoS One. 2017;12:e0173173.
    PubMed     Text format     Abstract available

  58. PATHMANATHAN I, Dokubo EK, Shiraishi RW, Agolory SG, et al
    Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0173309.
    PubMed     Text format     Abstract available

  59. MUHLE M, Lehmann M, Hoffmann K, Stern D, et al
    Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.
    PLoS One. 2017;12:e0173454.
    PubMed     Text format     Abstract available

  60. SUN D, Ahn H, Lievens T, Zeng W, et al
    Evaluation of the performance of national health systems in 2004-2011: An analysis of 173 countries.
    PLoS One. 2017;12:e0173346.
    PubMed     Text format     Abstract available

  61. CORADO AL, Bello G, Leao RA, Granja F, et al
    HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil.
    PLoS One. 2017;12:e0173894.
    PubMed     Text format     Abstract available

  62. HU Z, Chen J, Wang J, Xiong Q, et al
    Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients.
    PLoS One. 2017;12:e0173858.
    PubMed     Text format     Abstract available

  63. WELDEHAWERIA NB, Abreha EH, Weldu MG, Misgina KH, et al
    Psychosocial correlates of nutritional status among people living with HIV on antiretroviral therapy: A matched case-control study in Central zone of Tigray, Northern Ethiopia.
    PLoS One. 2017;12:e0174082.
    PubMed     Text format     Abstract available

  64. DUQUE J, Gaga S, Clark D, Muller M, et al
    Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals.
    PLoS One. 2017;12:e0173983.
    PubMed     Text format     Abstract available

  65. AUSTIN-EVELYN K, Rabkin M, Macheka T, Mutiti A, et al
    Community health worker perspectives on a new primary health care initiative in the Eastern Cape of South Africa.
    PLoS One. 2017;12:e0173863.
    PubMed     Text format     Abstract available


    Science

  66. HAYNES BF, Burton DR
    Developing an HIV vaccine.
    Science. 2017;355:1129-1130.
    PubMed     Text format    

  67. NALDINI L, Trono D, Verma IM
    Lentiviral vectors, two decades later.
    Science. 2016;353:1101-2.
    PubMed     Text format    


    Virology

  68. CROOKS ET, Osawa K, Tong T, Grimley SL, et al
    Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.
    Virology. 2017;505:193-209.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: